SGER: Antibody-Conjugated Nanoparticle Films as Spectroscopic Sensors of Chemical Agents
SGER:抗体偶联纳米粒子薄膜作为化学试剂的光谱传感器
基本信息
- 批准号:0228143
- 负责人:
- 金额:$ 10万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Standard Grant
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-09-01 至 2004-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
0228143WeiThe proposed work will fabricate robust, antibody-conjugated gold nanoparticle films as substrates for surface-enhanced Raman scattering (SERS), a sensitive spectroscopic method with unmet potential for label-free chemical sensing. The SERS activities of the nanoparticle-based substrates will be optimized as a function of interparticle spacing and periodic order. Initial tests will be performed to recognize 2,4-dinitropohenol (DNP) in gas and aqueous environments and in the presence of several other aromatic compounds as a control for selectivity. The demonstration of substrates for selective chemical detection of DNP can be immediately parlayed into the development of Raman-based sensors of chemical warfare agents, including explosives, nerve gases, and mustard gases and vesicants. The structure-activity relationships are based on theoretical considerations alone and have no experimental precedence. However, the proposed research is hypothesis-driven and addresses both short-term objectives for chemical sensor development and fundamental issues on the plasmonic properties of nanostructured metal films, with subsequent potential for applications beyond chemical and biological sensing.
0228143 Wei拟议的工作将制造坚固的,抗体共轭的金纳米粒子薄膜作为表面增强拉曼散射(Sers),一个敏感的光谱方法与未满足的潜力,无标记的化学传感基板。 基于纳米颗粒的基底的Sers活性将被优化为颗粒间间距和周期顺序的函数。 将进行初步测试,以识别气体和水环境中的2,4-二硝基苯酚(DNP),并在存在其他几种芳香族化合物的情况下作为选择性的对照。 DNP的选择性化学检测底物的演示可以立即用于开发基于拉曼的化学战剂传感器,包括爆炸物,神经毒气,芥子气和起泡剂。 结构-活性关系仅基于理论考虑,没有实验优先性。 然而,拟议的研究是假设驱动的,解决了化学传感器开发的短期目标和纳米结构金属薄膜等离子体特性的基本问题,随后有可能应用于化学和生物传感之外。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alexander Wei其他文献
Preface: insights into an unsolved problem in drug delivery.
前言:对药物输送中尚未解决的问题的见解。
- DOI:
- 发表时间:
2012 - 期刊:
- 影响因子:10.8
- 作者:
Donald E Bergstrom;Alexander Wei - 通讯作者:
Alexander Wei
Optimal Las Vegas Approximate Near Neighbors in ℓp
- DOI:
10.1145/3461777 - 发表时间:
2022-01 - 期刊:
- 影响因子:0
- 作者:
Alexander Wei - 通讯作者:
Alexander Wei
Bayesian graph representation learning for adversarial patch detection
用于对抗性补丁检测的贝叶斯图表示学习
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
Alexander M. Berenbeim;Alexander Wei;Adam Cobb;Anirban Roy;Susmit Jha;Nathaniel D. Bastian - 通讯作者:
Nathaniel D. Bastian
Optimal Las Vegas Approximate Near Neighbors in l_p
- DOI:
- 发表时间:
2019-01 - 期刊:
- 影响因子:0
- 作者:
Alexander Wei - 通讯作者:
Alexander Wei
Allocation for Social Good: Auditing Mechanisms for Utility Maximization
社会公益分配:效用最大化的审计机制
- DOI:
10.1145/3328526.3329623 - 发表时间:
2019 - 期刊:
- 影响因子:0
- 作者:
Taylor Lundy;Alexander Wei;Hu Fu;S. Kominers;Kevin Leyton - 通讯作者:
Kevin Leyton
Alexander Wei的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alexander Wei', 18)}}的其他基金
CAS:Rigidochromism in Polynuclear Metal-azole Macrocycles and Networks
CAS:多核金属唑大环和网络中的刚性变色
- 批准号:
2204206 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Standard Grant
Nucleation and Growth of Anisotropic Magnetic Nanostructures
各向异性磁性纳米结构的成核和生长
- 批准号:
0957738 - 财政年份:2010
- 资助金额:
$ 10万 - 项目类别:
Standard Grant
Self-Assembly and Collective Properties of Resorcinarene-encapsulated Nanoparticles
间苯二酚封装纳米粒子的自组装和集体性能
- 批准号:
0243496 - 财政年份:2003
- 资助金额:
$ 10万 - 项目类别:
Standard Grant
Biophotonics: Gold Superparticles as Raman-active Nanoprobes of Molecular Transport Across Cell Membranes
生物光子学:金超粒子作为跨细胞膜分子运输的拉曼活性纳米探针
- 批准号:
0086804 - 财政年份:2000
- 资助金额:
$ 10万 - 项目类别:
Continuing Grant
相似海外基金
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Novel discovery of the antibody conjugated liposome for RAS/BRAF mutated colorectal and pancreatic cancers
针对 RAS/BRAF 突变结直肠癌和胰腺癌的抗体偶联脂质体的新发现
- 批准号:
23K15080 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of novel photodynamic diagnosis using antibody-conjugated photosensitizer for superselective accumulation to cancer
利用抗体偶联光敏剂对癌症进行超选择性积累,开发新型光动力诊断
- 批准号:
22K20862 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Targeted antibody-conjugated magnetic nanoparticles for the treatment of Alzheimer's disease
靶向抗体偶联的磁性纳米粒子用于治疗阿尔茨海默病
- 批准号:
10454814 - 财政年份:2021
- 资助金额:
$ 10万 - 项目类别:
Targeted antibody-conjugated magnetic nanoparticles for the treatment of Alzheimer's disease
靶向抗体偶联的磁性纳米粒子用于治疗阿尔茨海默病
- 批准号:
10314932 - 财政年份:2021
- 资助金额:
$ 10万 - 项目类别:
Development of 211Astatine-Conjugated Anti-CD45 Antibody-Based Conditioning for Hematopoietic Stem Cell Gene Therapy and Editing
用于造血干细胞基因治疗和编辑的基于 211Astatine 缀合抗 CD45 抗体的调理的开发
- 批准号:
10408783 - 财政年份:2020
- 资助金额:
$ 10万 - 项目类别:
Development of 211Astatine-Conjugated Anti-CD45 Antibody-Based Conditioning for Hematopoietic Stem Cell Gene Therapy and Editing
用于造血干细胞基因治疗和编辑的基于 211Astatine 缀合抗 CD45 抗体的调理的开发
- 批准号:
10159976 - 财政年份:2020
- 资助金额:
$ 10万 - 项目类别:
Development of 211Astatine-Conjugated Anti-CD45 Antibody-Based Conditioning for Hematopoietic Stem Cell Gene Therapy and Editing
用于造血干细胞基因治疗和编辑的基于 211Astatine 缀合抗 CD45 抗体的调理的开发
- 批准号:
10652510 - 财政年份:2020
- 资助金额:
$ 10万 - 项目类别:
Development of 211Astatine-Conjugated Anti-CD45 Antibody-Based Conditioning for Hematopoietic Stem Cell Gene Therapy and Editing
用于造血干细胞基因治疗和编辑的基于 211Astatine 缀合抗 CD45 抗体的调理的开发
- 批准号:
10687021 - 财政年份:2020
- 资助金额:
$ 10万 - 项目类别:
Development of exosome-capturing antibody-conjugated nucleic acid medicines against multiple myeloma
开发针对多发性骨髓瘤的外泌体捕获抗体缀合核酸药物
- 批准号:
19K08826 - 财政年份:2019
- 资助金额:
$ 10万 - 项目类别:
Grant-in-Aid for Scientific Research (C)